CDC vaccine advisers recommend Merck’s RSV therapy for babies

statnews.com/2025/06/26/cdc-acip-merck-rsv-monoclonal-antibody-enflonsia

A committee that advises the Centers for Disease Control and Prevention on vaccines voted Thursday to recommend the use of a new monoclonal antibody against RSV in babies, Merck’s Enflonsia.
The monoclonal antibody, given to babies under 8 months of age entering their first RSV season,…

This story appeared on statnews.com, 2025-06-27 13:48:26.013000.
The Entire Business World on a Single Page. Free to Use →